CXCR4 and brain neoplasm: CXCL12 is also upregulated in the brain tumor microvasculature, and blocking the CXCR4 axis with antagonists AMD3100 and AMD3465 resulted in significant anti-tumor effects in animal models [19, 20, 30-33].